{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-051841","form_type":"8-K","ticker":"HOOK","cik":"0001760542","company_name":"HOOKIPA Pharma Inc.","filed_at":"2025-05-22T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.617224+00:00","generated_at":"2026-05-20T18:34:02.260087+00:00","sec_items":["1.01","1.02","5.02","8.01","9.01"],"event_type":"m_and_a","sentiment":"negative","materiality_score":0.95,"calibrated_materiality_score":0.95,"confidence":"high","headline":"HOOKIPA to sell HB-400/HB-500 assets to Gilead for up to $10M; board approves dissolution","bullets":["Gilead to acquire HB-400 and HB-500 assets for up to $10M in cash; $3M at closing, up to $7M in transfer completion payments.","Board approved dissolution of HOOKIPA; filing of Certificate of Dissolution expected after Transfer Plan completion.","Asset sale and dissolution require stockholder approval; proxy statement to be filed for special meeting.","CEO Malte Peters receives severance, accelerated equity vesting, and a Special Dissolution Success Bonus up to €482,591.","Collaboration Agreement and Stock Purchase Agreement with Gilead will terminate at closing."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-051841","json":"https://secwatch.observer/filing/0001104659-25-051841.json","markdown":"https://secwatch.observer/filing/0001104659-25-051841.md","text":"https://secwatch.observer/filing/0001104659-25-051841.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1760542/000110465925051841/0001104659-25-051841-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1760542/000110465925051841/tm2515845d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-20T18:34:02.260087+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}